Association between stroke and Alzheimer's disease: Systematic review and meta-analysis

Journal of Alzheimer's Disease

Volumn 43, Issue 2, 2015, Pages 479-489

  Zhou, Jing ^a   Yu, Jin Tai ^a,b,c   Wang, Hui Fu ^c   Meng, Xiang Fei ^b   Tan, Chen Chen ^b   Wang, Jun ^b   Wang, Chong ^b   Tana, Lan ^a,b,c  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b QINGDAO UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; meta analysis; risk; stroke

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; DEMENTIA; DISEASE ASSOCIATION; EFFECT SIZE; HUMAN; BIBLIOGRAPHIC DATABASE; META ANALYSIS; STATISTICS AND NUMERICAL DATA; STROKE;

ALZHEIMER DISEASE; DATABASES, BIBLIOGRAPHIC; HUMANS; STROKE;

EID: 84911905720     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-140666     Document Type: Article

References (52)

1. Querfurth HW, LaFerla FM (2010) Alzheimer's disease. N Engl J Med 362, 329-344.
2. Terry AV, Jr. , Callahan PM, Hall B, Webster SJ (2011) Alzheimer's disease and age-related memorydecline (preclinical) . Pharmacol Biochem Behav 99, 190-210.
3. Tanzi RE, Bertram L (2005) Twenty years of the Alzheimer'sdisease amyloid hypothesis: A genetic perspective. Cell 120, 545-555.
4. Zhang ZX, Zahner GE, Roman GC, Liu J, Hong Z, Qu QM, Liu XH, Zhang XJ, Zhou B, Wu CB, Tang MN, Hong X, LiH (2005) Dementia subtypes in China: Prevalence in Beijing, Xian, Shanghai, and Chengdu. Arch Neurol 62, 447-453.
5. Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, et al. (1993) Associationof apolipoprotein E allele epsilon 4 with late-onsetfamilial and sporadic Alzheimer's disease. Neurology 43, 1467-1472.
6. Ashford JW, Mortimer JA (2002) Non-familial Alzheimer'sdisease is mainly due to genetic factors. J Alzheimers Dis 4, 169-177.
7. Hachinski V, Munoz D (2000) Vascular factors in cognitiveimpairment-where are we now Ann N Y Acad Sci 903, 1-5.
8. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson LA, Nilsson L, Persson G, Oden A, Svanborg A (1996) 15-yearlongitudinal study of blood pressure and dementia. Lancet347, 1141-1145.
9. Leibson CL, Rocca WA, Hanson VA, Cha R, Kokmen E, O'Brien PC, Palumbo PJ (1997) Risk of dementia among personswith diabetes mellitus: A population-based cohort study. Am J Epidemiol 145, 301-308.
10. Mortel KF, Wood S, Pavol MA, Meyer JS, Rexer JL (1993) Analysis of familial and individual risk factors among patientswith ischemic vascular dementia and Alzheimer's disease. Angiology 44, 599-605.
11. Hofman A, Ott A, Breteler MM, Bots ML, Slooter AJ, vanHarskamp F, van Duijn CN, Van Broeckhoven C, GrobbeeDE (1997) Atherosclerosis, apolipoprotein E, and prevalenceof dementia and Alzheimer's disease in the Rotterdam Study. Lancet 349, 151-154.
12. Ott A, Breteler MM, de Bruyne MC, van Harskamp F, Grobbee DE, Hofman A (1997) Atrial fibrillation and dementiain a population-based study. The Rotterdam Study. Stroke28, 316-321.
13. Kilander L, Andren B, Nyman H, Lind L, Boberg M, LithellH (1998) Atrial fibrillation is an independent determinant of lowcognitive function: A cross-sectional study in elderly men. Stroke 29, 1816-1820.
14. Kivipelto M, Helkala EL, Hanninen T, Laakso MP, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, NissinenA (2001) Midlife vascular risk factors and late-life mild cognitiveimpairment: A population-based study. Neurology 56, 1683-1689.
15. Cechetto DF, Hachinski V, Whitehead SN (2008) Vascularrisk factors and Alzheimer's disease. Expert Rev Neurother 8, 743-750.
16. White L, Petrovitch H, Hardman J, Nelson J, Davis DG, Ross GW, Masaki K, Launer L, Markesbery WR (2002) Cerebrovascular pathology and dementia in autopsiedHonolulu-Asia Aging Study participants. Ann N Y Acad Sci977, 9-23.
17. Sonnen JA, Larson EB, Crane PK, Haneuse S, Li G, Schellenberg GD, Craft S, Leverenz JB, Montine TJ (2007) Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol 62, 406-413.
18. Schneider JA, Bennett DA (2010) Where vascular meets neurodegenerativedisease. Stroke 41, S144-S146.
19. Kalaria RN, Ballard C (1999) Overlap between pathologyof Alzheimer disease and vascular dementia. Alzheimer DisAssoc Disord 13(Suppl 3) , S115-S123.
20. Schneider JA, Arvanitakis Z, Leurgans SE, Bennett DA (2009) The neuropathology of probable Alzheimer disease and mildcognitive impairment. Ann Neurol 66, 200-208.
21. Ferrucci L, Guralnik JM, Salive ME, Pahor M, Corti MC, Baroni A, Havlik RJ (1996) Cognitive impairment and riskof stroke in the older population. J Am Geriatr Soc 44, 237-241.
22. Qiu C, Xu W, Winblad B, Fratiglioni L (2010) Vascular riskprofiles for dementia and Alzheimer's disease in very old people:A population-based longitudinal study. J Alzheimers Dis20, 293-300.
23. Bermejo-Pareja F, Benito-Leon J, Vega S, Medrano MJ, Roman GC, Neurological Disorders in Central Spain StudyG (2008) Incidence and subtypes of dementia in three elderlypopulations of central Spain. J Neurol Sci 264, 63-72.
24. Hayden KM, Zandi PP, Lyketsos CG, Khachaturian AS, Bastian LA, Charoonruk G, Tschanz JT, Norton MC, Pieper CF, Munger RG, Breitner JC, Welsh-Bohmer KA, Cache CountyI (2006) Vascular risk factors for incident Alzheimer diseaseand vascular dementia: The Cache County study. AlzheimerDis Assoc Disord 20, 93-100.
25. Honig LS, Tang MX, Albert S, Costa R, Luchsinger J, Manly J, Stern Y, Mayeux R (2003) Stroke and the risk of Alzheimerdisease. Arch Neurol 60, 1707-1712.
26. Vilalta-Franch J, Lopez-Pousa S, Llinas-Regla J, Calvo-Perxas L, Merino-Aguado J, Garre-Olmo J (2013) Depressionsubtypes and 5-year risk of dementia and Alzheimer disease inpatients aged 70 years. Int J Geriatr Psychiatry 28, 341-350.
27. Tolppanen AM, Lavikainen P, Solomon A, Kivipelto M, Soininen H, Hartikainen S (2013) Incidence of stroke inpeople with Alzheimer disease: A national register-basedapproach. Neurology 80, 353-358.
28. Chi NF, Chien LN, Ku HL, Hu CJ, Chiou HY (2013) Alzheimer disease and risk of stroke: A population-basedcohort study. Neurology 80, 705-711.
29. Higgins JP, Thompson SG (2002) Quantifying heterogeneityin a meta-analysis. Stat Med 21, 1539-1558.
30. Davranche K, McMorris T (2009) Specific effects of acutemoderate exercise on cognitive control. Brain Cogn 69, 565-570.
31. Tang MX, Cross P, Andrews H, Jacobs DM, Small S, Bell K, Merchant C, Lantigua R, Costa R, Stern Y, Mayeux R (2001) Incidence ofADin African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology 56, 49-56.
32. Luchsinger JA, Honig LS, Tang MX, Devanand DP (2008) Depressive symptoms, vascular risk factors, and Alzheimer'sdisease. Int J Geriatr Psychiatry 23, 922-928.
33. Lindsay J, Laurin D, Verreault R, Hebert R, Helliwell B, Hill GB, McDowell I (2002) Risk factors for Alzheimer's disease:A prospective analysis from the Canadian Study of Healthand Aging. Am J Epidemiol 156, 445-453.
34. Imfeld P, Bodmer M, Schuerch M, Jick SS, Meier CR (2013) Risk of incident stroke in patients with Alzheimer disease orvascular dementia. Neurology 81, 910-919.
35. Breteler MM (2000) Vascular risk factors for Alzheimer'sdisease: An epidemiologic perspective. Neurobiol Aging 21, 153-160.
36. Breteler MM, Bots ML, Ott A, Hofman A (1998) Riskfactors for vascular disease and dementia. Haemostasis 28, 167-173.
37. Tan ZS, Seshadri S, Beiser A, Wilson PW, Kiel DP, Tocco M, D'Agostino RB, Wolf PA (2003) Plasma total cholesterollevel as a risk factor for Alzheimer disease: The FraminghamStudy. Arch Intern Med 163, 1053-1057.
38. Neuropathology Group. Medical Research Council Cognitive F, Aging S (2001) Pathological correlates of late-onset dementiain a multicentre, community-based population in Englandand Wales. Neuropathology Group of the Medical ResearchCouncil Cognitive Function and Ageing Study (MRC CFAS) . Lancet 357, 169-175.
39. Roher AE, Esh C, Kokjohn TA, Kalback W, Luehrs DC, Seward JD, Sue LI, Beach TG (2003) Circle of willisatherosclerosis is a risk factor for sporadic Alzheimer's disease. Arterioscler Thromb Vasc Biol 23, 2055-2062.
40. Petrovitch H, Ross GW, Steinhorn SC, Abbott RD, Markesbery W, Davis D, Nelson J, Hardman J, Masaki K, Vogt MR, Launer L, White LR (2005) AD lesions and infarcts indemented and non-demented Japanese-American men. Ann Neurol 57, 98-103.
41. Dede DS, Yavuz B, Yavuz BB, Cankurtaran M, Halil M, Ulger Z, Cankurtaran ES, Aytemir K, Kabakci G, Ariogul S (2007) Assessment of endothelial function in Alzheimer's disease: IsAlzheimer's disease a vascular disease J Am Geriatr Soc 55, 1613-1617.
42. Cadavid D, Mena H, Koeller K, FrommeltRA (2000) Cerebralbeta amyloid angiopathy is a risk factor for cerebral ischemicinfarction. A case control study in human brain biopsies. J Neuropathol Exp Neurol 59, 768-773.
43. Olichney JM, Hansen LA, Hofstetter CR, Grundman M, Katzman R, Thal LJ (1995) Cerebral infarction in Alzheimer'sdisease is associated with severe amyloid angiopathy and hypertension. Arch Neurol 52, 702-708.
44. Mandybur TI (1975) The incidence of cerebral amyloidangiopathy in Alzheimer's disease. Neurology 25, 120-126.
45. Schneider JA, Arvanitakis Z, Bang W, Bennett DA (2007) Mixed brain pathologies account for most dementia casesin community-dwelling older persons. Neurology 69, 2197-2204.
46. Rogers RL, Meyer JS, Mortel KF (1990) After reaching retirementage physical activity sustains cerebral perfusion andcognition. J Am Geriatr Soc 38, 123-128.
47. Dustman RE, Ruhling RO, Russell EM, Shearer DE, Bonekat HW, Shigeoka JW, Wood JS, Bradford DC (1984) Aerobicexercise training and improved neuropsychological functionof older individuals. Neurobiol Aging 5, 35-42.
48. Gomez-Pinilla F, Dao L, So V (1997) Physical exerciseinduces FGF-2 and its mRNA in the hippocampus. Brain Res764, 1-8.
49. Cotman CW, Engesser-Cesar C (2002) Exercise enhances andprotects brain function. Exerc Sport Sci Rev 30, 75-79.
50. Schneider JA, Aggarwal NT, Barnes L, Boyle P, Bennett DA (2009) The neuropathology of older persons with and withoutdementia from community versus clinic cohorts. J Alzheimers Dis 18, 691-701.
51. Vermeer SE, Koudstaal PJ, Oudkerk M, Hofman A, Breteler MM (2002) Prevalence and risk factors of silent brain infarctsin the population-based Rotterdam Scan Study. Stroke 33, 21-25.
52. Khachaturian AS, Zandi PP, Lyketsos CG, Hayden KM, Skoog I, Norton MC, Tschanz JT, Mayer LS, Welsh-Bohmer KA, Breitner JC (2006) Antihypertensive medication use andincident Alzheimer disease: The Cache County Study. ArchNeurol 63, 686-692.